US Stock MarketDetailed Quotes
EOLS Evolus
- 11.890
- -0.200-1.65%
Close Apr 15 16:00 ET
729.74MMarket Cap-11009P/E (TTM)
12.210High11.860Low965.41KVolume12.210Open12.090Pre Close11.52MTurnover2.35%Turnover RatioLossP/E (Static)61.37MShares15.43352wk High-35.28P/B488.21MFloat Cap7.07052wk Low--Dividend TTM41.06MShs Float39.500Historical High--Div YieldTTM2.90%Amplitude2.850Historical Low11.934Avg Price1Lot Size
About Evolus Company
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Company Profile
SymbolEOLS
Company NameEvolus
Listing DateFeb 8, 2018
Issue Price12.00
Founded2012
CEOMr. David Moatazedi
MarketNASDAQ
Employees273
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address520 Newport Center Drive,Suite 1200
CityNewport Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92660
Phone1-949-284-4555
Websitehttp://www.evolus.com
Company Executives
- Name
- Position
- Salary
- David Moatazedi
- Director, President and Chief Executive Officer
- 3.60M
- Sandra Beaver
- Chief Financial Officer
- 1.83M
- Dr. Rui Avelar, M.D.
- Head of Research and Development and Chief Medical Officer
- 1.26M
- Vikram Malik
- Chairman of the Board
- 247.70K
- Robert Hayman
- Independent Director
- 225.70K
- David N. Gill
- Independent Director
- 240.20K
- Karah Parschauer
- Independent Director
- 238.20K
- Brady Stewart
- Independent Director
- 275.00K
- Simone Blank
- Independent Director
- 210.70K
- Dr. Peter C. Farrell, A.M.,PhD
- Independent Director
- 225.70K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg